Regulation of whole blood tumor necrosis factor production upon endotoxin stimulation after severe blunt trauma

Journal of Trauma - Injury, Infection and Critical Care

Volumn 43, Issue 6, 1997, Pages 880-887

  Majetschak, M ^a   Flach, R ^a   Heukamp, T ^a   Jennissen, V ^a   Obertacke, U ^a   Neudeck, F ^a   Schmit Neuerburg, K P ^a   Schade, F U ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Blood; Cytokine biosynthesis; Cytokines; Endotoxin; IL 10; Inhibitor; mRNA; Multiple organw failure; Sepsis; Shock; TGF ; TNF ; Trauma

Indexed keywords

CYTOKINE; ENDOTOXIN; INTERLEUKIN 10; MESSENGER RNA; PROSTAGLANDIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; BLOOD LEVEL; BLUNT TRAUMA; CLINICAL ARTICLE; CLINICAL PROTOCOL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; INJURY SCALE; LEUKOCYTE FUNCTION; MALE; MULTIPLE TRAUMA; PRIORITY JOURNAL;

EID: 0031442798     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005373-199712000-00002     Document Type: Article

References (40)

1. American College of Chest Physicians-Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864.
2. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). JAMA. 1995; 273:117.
3. Akina S, Toga T, Kishimoto T. Interleukin 6 in biology and medicine. Adv Immunol. 1993;54:1.
4. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med. 1993;119:771.
5. Dinarello CA, Mier JW. Current concepts: lymphokines. N Engl J Med. 1987;317:940.
6. Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med. 1993;328:106.
7. Waage A, Redl H, Schlag G, Schade FU. The cytokine network in trauma and sepsis II: IL1 and IL6. In: Schlag G, Redl H. eds. Pathophysiology of Shock, Sepsis, and Organ Failure. Berlin, Germany: Springer-Verlag; 1993:491.
8. Donnelly TJ, Meade P, Jagels M, et al. Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury. Crit Care Med. 1994;22:768.
9. Hoch RC, Rodriguez R, Manning T, et al. Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med. 1993;21:839.
10. Meade P, Shoemaker WC, Donnelly TJ, et al. Temporal patterns of hemodynamics, oxygen transport, cytokine activity, and complement activity in the development of adult respiratory distress syndrome after severe injury. J Trauma. 1994;36:651.
11. Svoboda P, Kantorová I, Ochmann J. Dynamics of interleukin 1, 2, and 6 and tumor necrosis factor alpha in multiple trauma patients. J Trauma. 1994;36:336.
12. Rabinovici R, John R, Esser KM, Vernick J, Feuerstein G. Serum tumor necrosis factor-alpha profile in trauma patients. J Trauma. 1993;35:698.
13. Ayala A, Wang P, Ba ZF. Differential alterations in plasma IL-6 and TNF levels after trauma and hemorrhage. Am J Physiol. 1991;260:R167.
14. Moore FA, Moore EE, Poggetti R, et al. Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma. J Trauma. 1991;31:629.
15. Tan LR, Waxman K, Scanell G, Ioli G, Granger GA. Trauma causes early release of soluble receptors for tumor necrosis factor. J Trauma. 1993;34:634.
16. DiPiro JT, Howdieshell TR, Goddard JT, Callaway DB, Hamilton RG, Mansberger AR. Association of interleukin 4 plasma levels with traumatic injury and clinical course. Arch Surg. 1995;130:1159.
17. Cinnat M, Waxman K, Granger GA, Pearce W, Annas C. Daughters K. Trauma causes sustained elevation of soluble tumor necrosis factor receptors. J Am Coll Surg. 1994; 179:529.
18. Cinnat M, Waxman K, Vaziri ND, et al. Soluble cytokine receptors and receptor antagonists are sequentially released after trauma. J Trauma. 1995;39:112.
19. Borrelli E, Roux-Lombard P, Grau GE, et al. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med. 1996; 24:392.
20. Haskill S, Hohnson C, Eierman D, Becker S, Warren K. Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes. J Immunol. 1988;140:1690.
21. Greenspan L, McLellan BA, Greig H. Abbreviated Injury Scale and Injury Severity Score: a scoring chart. J Trauma. 1985;25:64.
22. Teasdale S, Jennett B. Assessment of coma and impaired consciousness. Lancet. 1974;26:81.
23. Espevik T, Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods. 1986;95:99.
24. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156.
25. Seatter SC, Bennet T, Li MH, Bubrick MP, West MA. Macrophage endotoxin tolerance. Arch Surg. 1994;129:1263.
26. Melby CP, Darnell BJ, Tyron VV. Quantitative measurement of human cytokine gene expression by polymerase chain reaction. J Immunol Methods. 1993;159:235.
27. Marmenout A, Fransen L, Tavernier J, et al. Molecular cloning and expression of human tumor necrosis factor and comparison with mouse tumor necrosis factor. Eur J Biochem. 1985;152:515.
28. Sharp PA, Sugden B, Sambroock J. Detection of two restriction endonuclease activities in Haemophilus parainfluenzae using analytical agarose-ethidium bromide electrophoresis. Biochemistry. 1973;16:3055.
29. Fabian TC, Croce MA, Fabian MJ, et al. Reduced tumor necrosis factor production in endotoxin-spiked whole blood after trauma: experimental results and clinical correlation. Surgery. 1995;118:63.
30. Randow F, Syrbe U, Meisel C, et al. Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor β. J Exp Med. 1995;181:1887.
31. Faist E, Schinke C, Zimmer S, et al. The influence of major trauma on the regulatory levels of interleukin-1 (IL-1) and IL-2 in human mononuclear leukocytes. Zentralbl Chir. 1994;118:420.
32. Van Deventer SJH, Büller HR, ten Cate JW, Sturck A, Pauw W. Endotoxaemia: an early predictor of septicaemia in febrile patients. Lancet. 1988;1:605.
33. Haziot A, Rong GW, Bazil V, Silver J, Goyert SM. Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-α production by cells in whole blood. J Immunol. 1994;152:5868.
34. Krüger C, Schütt C, Obertacke U, et al. Serum CD14 levels in polytraumatized and severely burned patients. Clin Exp Immunol. 1991;85:297.
35. Ertel W, Kremer J-P, Kenney J, et al. Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood. 1995;85:1341.
36. Döcke WD, Syrbe U, Meinecke A, et al. Improvement of monocyte function: a new therapeutic approach? In: Reinhart K, Eyrich K, Sprung C, eds. Sepsis: Update in Intensive Care and Emergency Medicine. Berlin, Germany: Springer-Verlag; 1994;18:473.
37. Christou NV, Meakins JL. Neutrophil function in surgical patients: two inhibitors of granulocyte chemotaxis associated with sepsis. J Surg Res. 1979;26:355.
38. Wolfe JHN, Saporoschetz I, Young AE. Suppressive serum, suppressor lymphocytes, and death from burns. Ann Surg. 1981;193:513.
39. Lanser ME, Mao P, Brown GE, Coleman B, Siegel JH. Serum-mediated depression of neutrophil chemiluminescence following blunt trauma. Ann Surg. 1985;202:111.
40. Lanser ME, Brown GE, Mora R, Coleman B, Siegel JH. Trauma serum suppresses superoxide production by normal neutrophils. Arch Surg. 1986;121:157.